Compare UPL with Similar Stocks
Dashboard
With a growth in Operating Profit of 53.86%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 2 consecutive quarters
- PAT(Latest six months) At Rs 879.05 cr has Grown at 87.43%
- PBT LESS OI(Q) At Rs 635.00 cr has Grown at 144.23%
- ROCE(HY) Highest at 9.66%
With ROCE of 9.9, it has a Very Attractive valuation with a 1.4 Enterprise value to Capital Employed
High Institutional Holdings at 57.72%
Stock DNA
Pesticides & Agrochemicals
INR 56,552 Cr (Mid Cap)
25.00
28
0.90%
0.79
7.46%
1.76
Total Returns (Price + Dividend) 
Latest dividend: 6 per share ex-dividend date: Jul-11-2025
Risk Adjusted Returns v/s 
Returns Beta
News

UPL Ltd. Hits Intraday High with 5.2% Surge on 2 February 2026
UPL Ltd. demonstrated robust intraday performance on 2 Feb 2026, surging to an intraday high of Rs 706.9, marking a 6.24% increase and closing the day with a 5.2% gain. This notable uptick outpaced both its sector and the broader market indices, reflecting a significant rebound after two days of decline.
Read full news article
UPL Ltd. Hits Intraday Low Amid Price Pressure on 1 Feb 2026
Shares of UPL Ltd., a key player in the Pesticides & Agrochemicals sector, declined sharply today, touching an intraday low of Rs 644.65, down 8.44% from previous levels. The stock underperformed both its sector and the broader market amid widespread selling pressure and a negative market environment.
Read full news article
UPL Ltd. is Rated Buy by MarketsMOJO
UPL Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article Announcements 
Listing Of Global Depository Receipts (Gdrs) Of UPL Limited On NSE IX
29-Jan-2026 | Source : BSEPlease find enclosed letter dated January 29 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27-Jan-2026 | Source : BSEPlease find enclosed letter dated January 27 2026.
Board Meeting Intimation for The Quarter And Nine Months Period Ended December 31 2025.
27-Jan-2026 | Source : BSEUPL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 inter alia to consider and approve unaudited consolidated and standalone financial results of the Company for the quarter and nine months ended December 31 2025 along with the Limited Review Reports to be issued by the Statutory Auditors of the Company.
Corporate Actions 
(02 Feb 2026)
UPL Ltd. has declared 300% dividend, ex-date: 11 Jul 25
No Splits history available
UPL Ltd. has announced 1:2 bonus issue, ex-date: 02 Jul 19
UPL Ltd. has announced 1:8 rights issue, ex-date: 26 Nov 24
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
FIIs
None
Held by 36 Schemes (7.68%)
Held by 846 FIIs (38.84%)
Nerka Chemicals Pvt Ltd (21.41%)
Life Insurance Corporation Of India (5.31%)
6.57%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 12.49% vs 10.32% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -52.17% vs 168.04% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 5.35% vs 5.35% in Sep 2024
Growth in half year ended Sep 2025 is 156.23% vs -3,495.65% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 7.85% vs 7.04% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 86,000.00% vs 100.08% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 8.21% vs -19.56% in Mar 2024
YoY Growth in year ended Mar 2025 is 174.75% vs -133.61% in Mar 2024






